# Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct05996159` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05996159](<https://clinicaltrials.gov/study/NCT05996159>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05996159

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05996159. Randomized; no masking; primary purpose treatment. Start 2023-11-07 (actual); primary completion 2026-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05996159, source copy `cardio:ctgov-nct05996159-2026-05-20`, retrieved 2026-10-26)
- Started: 2023-11-07 (actual) (ClinicalTrials.gov record NCT05996159, source copy `cardio:ctgov-nct05996159-2026-05-20`, retrieved 2026-10-26)
- Primary completion: 2026-07-30 (anticipated) (ClinicalTrials.gov record NCT05996159, source copy `cardio:ctgov-nct05996159-2026-05-20`, retrieved 2026-10-26)
- Completion: 2027-05-01 (anticipated) (ClinicalTrials.gov record NCT05996159, source copy `cardio:ctgov-nct05996159-2026-05-20`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT05996159, source copy `cardio:ctgov-nct05996159-2026-05-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05996159-2026-05-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): QDOT MicroTM catheter
- Intervention (Device): AI-guided ablation only for PVI
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)

## Provenance

Content hash: 17bc7e051b4b77e0cca0ff9d216e6fc390810f1a5c95947ce58998d00a11f062
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
